NCT05753436View on ClinicalTrials.gov

Curcumin's Effect on Diabetic Patients With Atherosclerotic Cardiovascular Risk

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

March 1, 2024

Conditions
Diabetes Mellitus, Type 2DyslipidemiasHypertension
Interventions
DIETARY_SUPPLEMENT

Puritans Pride Turmeric curcumin® 500 mg

Turmeric curcumin 500 mg per oral capsule of Puritans Pride company supplement composed of Turmeric (curcuma longa) root 450mg and Turmeric extract (curcuma longa root 50mg ) standardized to contain 95%curcuminoids.It is added because of its possibility to reduce the risk of ASCVD by lowering blood pressure, lipid profile, blood glucose, inflammation, and oxidative stress.

Trial Locations (1)

Unknown

Demerdash Hospital, Faculty of Medicine, Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05753436 - Curcumin's Effect on Diabetic Patients With Atherosclerotic Cardiovascular Risk | Biotech Hunter | Biotech Hunter